Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118496071A details a novel one-pot method using heavy water and NHC catalysts for high-purity deuterated intermediates ensuring supply chain stability.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Novel oxaspiro diphosphine ligand synthesis enables >99% ee hydrogenation. Reliable supplier for high-purity chiral intermediates.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN105017043A reveals a mild synthesis method for alpha-amino acid derivatives. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel ionic liquid catalysis method for high-purity pharmaceutical intermediates with reduced waste and simplified purification ensuring reliable supply chain efficiency.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN104151283A reveals green ionic liquid catalysis for xanthene derivatives. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Patent CN113292393A reveals a mild SmI2-catalyzed reductive deuteration of acyl fluorides. This method offers high deuterium incorporation and superior chemoselectivity for manufacturing deuterated pharmaceutical intermediates.
Novel benzophenone-catalyzed method eliminates noble metals. High yield (>95%) cyclopropanation for fragrance intermediates. Cost-effective and scalable synthesis.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Novel catalytic route for benzofuran-2(3H)-one reduces steps and costs. Ideal for azoxystrobin production. High purity pharma intermediates available.
Patent CN114478290A reveals a metal halide catalyzed route for oseltamivir intermediates, offering superior purity and yield without column chromatography for reliable supply chains.
Patent CN102947000A details Z-M-OR complexes for efficient C-H and N-H carboxylation. Enables sustainable API intermediate synthesis using renewable CO2 feedstock.
Patent CN116462644B reveals a novel synthesis route for Lifitegrast intermediates offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN105669747B reveals a novel ytterbium catalyst for α-hydroxy phosphate synthesis, offering mild conditions and significant supply chain cost advantages.
Patent CN112608269B introduces a mild chalcogen weak interaction method for pyrrolidine synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.